What is the role of consolidation therapy in the treatment of acute promyelocytic leukemia (APL)?

Updated: Jul 02, 2019
  • Author: Sandy D Kotiah, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Consolidation therapy is based on the potential risk of relapse in patients who undergo induction therapy. Its main goal is to convert morphologic and cytogenetic remission into durable molecular remission. [9]

Again, several regimens are commonly used for consolidation therapy, including the European LeukemiaNet regimen, the European APL regimen, and the PETHEMA regimen. [10]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!